Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ciba-Geigy and Sandoz merged in $27 billion deal

Executive Summary

Ciba-Giegy and Sandoz merged creating the number 2 drug company (behind Glaxo Wellcome) in a $27 billion stock swap. The combined company called Novartis will have estimated annual sales of $27.27bn (36bn Swiss francs) in 1997.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies